Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
GEW hopes to spark innovation, connections among entrepreneurs
Global Entrepreneurship Week is about helping businesses that start in Kansas City stay in Kansas City, Jenny Miller said. And it’s for more than the traditional “startup” crowd, the network builder at KCSourceLink said. “GEWKC connects people who may not identify as ‘entrepreneurs’ – those who may think of themselves as makers, creators, freelancers, artists,…
Hip hop entrepreneur: Rap stardom isn’t the only way to a paycheck
Music is everything, Kartez Marcel said. It’s an avenue to express anger and hurt in a positive way. It’s a way to heal. And for aspiring entrepreneurs, it’s an opportunity to earn a paycheck even if they aren’t destined for on-stage superstardom, said Marcel, a Kansas City rapper and hip hop industry mentor. “Everybody wants…
FAQ: Is it all hype? Tunneling into Missouri’s chances for Hyperloop
Virgin Hyperloop One might seem like a pipe dream. But the prospect of Kansas Citians reaching St. Louis in only 23 minutes is more realistic than many think. In fact, according to recent reports, Missouri has at least a 20 percent chance at landing Hyperloop, a yet-to-be-realized transportation system that moves people and freight at…
CEO: Infusion Express $13.5M round proves realistic investment can come to KC
When Kansas City-based Infusion Express closed a $13.5 million Series B round earlier this month with McKesson Ventures as its lead investor, the move wasn’t a fluke, Don Peterson said. “If you build something really great, the money will find you,” said Peterson, CEO of Infusion Express. “I didn’t call McKesson, they called me. When…